Clinical Prognostic Score to Predict Relapse in VL
Comprehensive Clinical and Laboratory Assessment of Visceral Leishmaniasis to Develop Clinical Prognostic Tools to Predict Relapse: a Prospective Cohort Study in Ethiopia
Institute of Tropical Medicine, Belgium
741 participants
Feb 3, 2023
OBSERVATIONAL
Conditions
Summary
This prospective cohort study has the aim to develop a prognostic tool to predict relapse in patients suffering from visceral leishmaniasis (VL) from VL endemic regions in Ethiopia. Therefore, comprehensive clinical and laboratory characterization of all confirmed VL patients before and during treatment will be performed in order to identify the factors that determine prognosis of the patients. This approach would result in more efficient patient care and would reduce the case fatality and morbidity, and improve follow-up and care for those at risk of VL relapse.
Eligibility
Inclusion Criteria1
- clinically or parasitologically confirmed VL
Exclusion Criteria5
- Age under 12 years
- VL patients already on treatment for 3 days or more
- Severe critical condition or other circumstances that make the study medically inadvisable
- Unlikely to adhere to follow up visits during the study period (e.g. patients who live or work very far away) AND not reachable by phone for follow-up information
- Pregnant or lactating woman
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
No intervention
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05602610